-transparent.png){kind=logo}
A group of 20 patients who met the DSM-III-R criteria for panic disorder with or without agoraphobia underwent a 35% carbon dioxide (CO2) challenge after either 1 mg alprazolam or placebo in a double-blind, randomized, cross-over design. Despite the anxiolytic potential of alprazolam, it produced no significant effects on CO2-induced anxiety and panic symptomatology when compared to placebo.
Related Publications
H Pols, and
K Verburg, and
R Hauzer, and
J Meijer, and
E Griez
September 1986,
Archives of general psychiatry,
H Pols, and
K Verburg, and
R Hauzer, and
J Meijer, and
E Griez
June 2007,
Human psychopharmacology,
H Pols, and
K Verburg, and
R Hauzer, and
J Meijer, and
E Griez
August 2015,
Psychiatry research,
H Pols, and
K Verburg, and
R Hauzer, and
J Meijer, and
E Griez
March 1987,
Journal of behavior therapy and experimental psychiatry,
H Pols, and
K Verburg, and
R Hauzer, and
J Meijer, and
E Griez
March 2004,
Psychiatry research,
H Pols, and
K Verburg, and
R Hauzer, and
J Meijer, and
E Griez
January 2006,
Depression and anxiety,
H Pols, and
K Verburg, and
R Hauzer, and
J Meijer, and
E Griez
January 2007,
Progress in neuro-psychopharmacology & biological psychiatry,
H Pols, and
K Verburg, and
R Hauzer, and
J Meijer, and
E Griez
August 2007,
Progress in neuro-psychopharmacology & biological psychiatry,
H Pols, and
K Verburg, and
R Hauzer, and
J Meijer, and
E Griez
March 2001,
Psychiatry research,
H Pols, and
K Verburg, and
R Hauzer, and
J Meijer, and
E Griez
March 2010,
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry,
